Astec Lifesciences has raised Rs 49 crore through the allotment of 4,900 Rated, Listed, Unsecured, Redeemable, Non-Convertible Debentures (NCDs) having a face value of Rs 1,00,000 each, to an eligible investor. The Managing Committee of the Board of Directors of the Company at their meeting held on August 22, 2023, has allotted the same.
Astec Lifesciences manufactures a wide range of agrochemicals and pharmaceutical intermediates.